ENVESTNET ASSET MANAGEMENT INC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1407543 Berwyn, PA

Position in RXRX

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$706,443

+$209,742 QoQ

Shares Held

230,112

+89.5% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ENVESTNET ASSET MANAGEMENT INC holds $767,426,760 across 109 Biotechnology names. RXRX ranks #66 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	503,564	$224,861,468
2	REGN	Regeneron Pharmaceuticals, Inc.	109,152	$84,335,201
3	ALNY	Alnylam Pharmaceuticals, Inc.	171,797	$56,842,473
4	INSM	INSMED Inc	299,925	$49,043,736
5	ARGX	Argenx SE	61,418	$44,850,494
6	RPRX	Royalty Pharma plc	495,892	$23,787,939
7	GMAB	Genmab A/S	862,301	$23,135,535
8	ROIV	Roivant Sciences Ltd.	678,518	$18,794,948

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$706,443	230,112	+89.5%	Shares	Sole	2026-05-04
2025-12-31	$496,701	121,443	-30.6%	Shares	Sole	2026-02-10
2025-09-30	$854,561	175,115	-7.8%	Shares	Sole	2025-11-05
2025-06-30	$960,899	189,901	-7.8%	Shares	Sole	2025-08-01
2025-03-31	$1,089,173	205,893	-11.2%	Shares	Sole	2025-04-29
2024-12-31	$1,566,670	231,756	+5.3%	Shares	Sole	2025-02-13
2024-09-30	$1,450,524	220,110	+52.7%	Shares	Sole	2024-11-07
2024-06-30	$1,081,020	144,136	+7.6%	Shares	Sole	2024-08-08
2024-03-31	$1,335,182	133,920	+5.1%	Shares	Sole	2024-05-13
2023-12-31	$1,256,558	127,440	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.